Pathfinder Cell Therapy Inc. | |
Stock Exchange | Other OTC |
EPS |
- |
Market Cap |
$533.73 K |
Shares Outstanding |
667.16 M |
Public Float |
- |
Address |
12 Bow Street Cambridge Massachusetts 02138 United States |
Employees | - |
Website | http://www.pathfindercelltherapy.com |
Updated | 07/08/2019 |
Pathfinder Cell Therapy, Inc. is a development stage regenerative medicine company. It focuses on developing a novel cell-based therapy for the treatment of diabetes, renal disease, myocardial infarction, and other diseases characterized by organ-specific cell damage. The company was founded by Richard L. |